Newel Health develops AI-driven digital medical devices and Software as a Medical Device (SaMD) for chronic conditions like cardiometabolic disorders, neurological issues, and chronic pain. Their H.Core platform integrates regulatory compliance, behavioral science, and real-world data to rapidly build and scale clinical-grade software solutions. The company provides regulator-approved digital therapeutics that support sustained patient lifestyle change and continuous symptom management.
Funding
$2.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Developing digital therapeutics (DTx) and digital medicine solutions in-house presents significant challenges for traditional healthcare stakeholders like pharmaceutical companies, insurers, and providers. The process demands specialized expertise, resources, and strategic partnerships that are often outside their core competencies.
Solution
Newel Health offers a comprehensive, turnkey solution for developing and commercializing digital medicine and digital therapeutics (DTx) in partnership with pharmaceutical and medical device companies. Leveraging the H.Core framework, Newel Health's team of digital, data, behavioral, and scientific experts accelerates the development process while ensuring compliance and security. This integrated approach enables partners to deliver advanced digital solutions that enhance patient engagement and outcomes without the burdens of in-house development, accommodating the dynamic needs of healthcare research, validation, certification, and market delivery. Newel Health's DM and DTx products undergo rigorous research, design, and usability processes, validated through Randomized Clinical Trials (RCT) and leveraging Real World Evidence (RWE) to bridge the gap between clinical research and real-life outcomes.
Target Audience
Newel Health primarily serves pharmaceutical and medical device companies, as well as other healthcare stakeholders, seeking to develop and commercialize digital medicine and digital therapeutic solutions.
Features
- H.Core framework for rapid DTx development, ensuring compliance and security
- Amicomed: Hypertension control app with blood pressure trend analysis and personalized lifestyle modification
- Soturi: Digital service platform for Parkinson’s Disease, featuring symptom tracking, medication reminders, and rehabilitation programs
- Rohkea: VR-based digital therapeutic for chronic back pain, designed to increase physical activity
- ISO 27001, ISO 13485, and ISO 9001 certifications, demonstrating commitment to quality management, medical device standards, and information security
- User-centered design approach, incorporating behavioral science and empathy to improve efficacy and engagement